Today, 300 million people globally suffer from asthma and chronic lung diseases, suffering attacks of breathlessness and wheezing. Teva is proud to be the second largest global supplier of medicines on the World Health Organization’s (WHO) Essential Medicines List for respiratory conditions. While these diseases are often chronic, the greatest assistance for those living with these conditions is to provide a treatment which can be carried with them and can be administered as efficiently as possible. Accordingly, key to our work developing asthma treatments is improving the efficiency of inhalers for both maintenance and rescue therapies. Our innovative and growing portfolio of digitally integrated combination treatment options has the potential to change the future of care for the respiratory community.
Sincerely Pharmaceutical Tech
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling